Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines

Leuk Res. 2009 Feb;33(2):321-5. doi: 10.1016/j.leukres.2008.08.007. Epub 2008 Sep 11.

Abstract

Glucocorticoids (GCs) are among the most important drugs for the treatment of acute lymphoblastic leukaemia (ALL). Cell lines cultured in high GC concentrations typically contain mutated glucocorticoid receptor (GR), something that is rarely found in primary ALL specimens. We studied naturally occurring mechanisms of GC resistance and examined sensitivity to GC in 15 T-ALL cell lines grown without prior exposure to drugs. Resistance could not be attributed to mutations in GR or variations in levels of its expression. We conclude that this panel of cell lines provides a suitable in vitro model since it reflects GC resistance in primary ALL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Dexamethasone / pharmacology
  • Drug Resistance, Neoplasm*
  • Glucocorticoids / pharmacology*
  • Humans
  • Methylprednisolone / pharmacology
  • Mutation*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology*
  • Receptors, Glucocorticoid / genetics*

Substances

  • Glucocorticoids
  • Receptors, Glucocorticoid
  • Dexamethasone
  • Methylprednisolone